The purpose of the present research work is to carryout pre-clinical and open clinical study on Benign Prostatic Hyperplasia. Clinically, BPH is distinguished by the progressive development of Lower Urinary Tract Syndrome (LUTS). According to NIH there are more than 7.8 million BPH diagnoses made per year. BPH is the 5th most prevalent non-cancer-related disorder among men aged 50 years and older. Economic burden of BPH accounts for seventh highest 1-year disease specific medical costs. The specific approach used to treat BPH depends upon number of factors like age, prostate size, weight, prostate-specific antigen level, and severity of the symptoms. The Herbo-mineral Siddha drug ‘Velvanga Parpam’ has unique effect on BPH, it decrease the solid tumour volume in drug treated animals and reduction of International Prostate Symptoms Score (IPSS) in BPH Patients. These data confirms that the Siddha drug ‘Velvanga Parpam’ can be used as a novel potential agent for BPH.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Author is now working as a Lecturer in the Dept. Of Physiology at V.M.Siddha Medical College. Also he worked as a Deputy Medical Superintendent in same institution.On 2014,more than 10 research and review papers published national and International journals.Completed his P.G in Govt. Siddha Medical College,Chennai at The TN DrMGR Medical Univesity.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The purpose of the present research work is to carryout pre-clinical and open clinical study on Benign Prostatic Hyperplasia. Clinically, BPH is distinguished by the progressive development of Lower Urinary Tract Syndrome (LUTS). According to NIH there are more than 7.8 million BPH diagnoses made per year. BPH is the 5th most prevalent non-cancer-related disorder among men aged 50 years and older. Economic burden of BPH accounts for seventh highest 1-year disease specific medical costs. The specific approach used to treat BPH depends upon number of factors like age, prostate size, weight, prostate-specific antigen level, and severity of the symptoms. The Herbo-mineral Siddha drug Velvanga Parpam has unique effect on BPH, it decrease the solid tumour volume in drug treated animals and reduction of International Prostate Symptoms Score (IPSS) in BPH Patients. These data confirms that the Siddha drug Velvanga Parpam can be used as a novel potential agent for BPH. 164 pp. Englisch. N° de réf. du vendeur 9783659255540
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Sam Raj K.Author is now working as a Lecturer in the Dept. Of Physiology at V.M.Siddha Medical College. Also he worked as a Deputy Medical Superintendent in same institution.On 2014,more than 10 research and review papers published n. N° de réf. du vendeur 5143457
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The purpose of the present research work is to carryout pre-clinical and open clinical study on Benign Prostatic Hyperplasia. Clinically, BPH is distinguished by the progressive development of Lower Urinary Tract Syndrome (LUTS). According to NIH there are more than 7.8 million BPH diagnoses made per year. BPH is the 5th most prevalent non-cancer-related disorder among men aged 50 years and older. Economic burden of BPH accounts for seventh highest 1-year disease specific medical costs. The specific approach used to treat BPH depends upon number of factors like age, prostate size, weight, prostate-specific antigen level, and severity of the symptoms. The Herbo-mineral Siddha drug 'Velvanga Parpam' has unique effect on BPH, it decrease the solid tumour volume in drug treated animals and reduction of International Prostate Symptoms Score (IPSS) in BPH Patients. These data confirms that the Siddha drug 'Velvanga Parpam' can be used as a novel potential agent for BPH.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 164 pp. Englisch. N° de réf. du vendeur 9783659255540
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The purpose of the present research work is to carryout pre-clinical and open clinical study on Benign Prostatic Hyperplasia. Clinically, BPH is distinguished by the progressive development of Lower Urinary Tract Syndrome (LUTS). According to NIH there are more than 7.8 million BPH diagnoses made per year. BPH is the 5th most prevalent non-cancer-related disorder among men aged 50 years and older. Economic burden of BPH accounts for seventh highest 1-year disease specific medical costs. The specific approach used to treat BPH depends upon number of factors like age, prostate size, weight, prostate-specific antigen level, and severity of the symptoms. The Herbo-mineral Siddha drug Velvanga Parpam has unique effect on BPH, it decrease the solid tumour volume in drug treated animals and reduction of International Prostate Symptoms Score (IPSS) in BPH Patients. These data confirms that the Siddha drug Velvanga Parpam can be used as a novel potential agent for BPH. N° de réf. du vendeur 9783659255540
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Management Of Benign Prostatic Hyperplasia (BPH) in Siddha System | Effect of Herbo-Mineral Siddha Drug 'Velvanga Parpam' | K. Sam Raj (u. a.) | Taschenbuch | 164 S. | Englisch | 2014 | LAP LAMBERT Academic Publishing | EAN 9783659255540 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 105316390
Quantité disponible : 5 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
paperback. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA82336592555486
Quantité disponible : 1 disponible(s)